ABSTRACT
OBJECTIVE: Zidovudine (AZT) is a primary drug therapy used to treat HIV-infected individuals. While AZT inhibits replication of HIV, it also induces a drug-specific myopathy resulting in altered muscle mitochondria, increased oxidative stress and muscle contractile dysfunction. The purpose of this study was to assess the impact of an antioxidant diet (high in vitamins C and E) on AZT-mediated diaphragmatic contractile dysfunction in rodents. METHODOLOGY: Adult, Sprague-Dawley rats were assigned to feeding groups: control (CON, n = 9), AZT-treatment (AZT, n = 8), antioxidant diet only (Anti-Ox, n = 6), and AZT + antioxidant diet (AZT + Anti, n = 9). Two costal diaphragm strips were removed from each animal (under surgical anaesthesia) and evaluated for force-frequency relationship, maximal specific tension, and fatigue resistance using an in vitro preparation. RESULTS: Results indicate significant reductions in normalized force production (20-200 Hz), including maximal specific tension, between AZT animals and all other groups. While AZT reduced diaphragm contractility, the addition of an antioxidant diet eliminated this decrease. CONCLUSION: These data suggest that an increase in oxidative stress mediated by AZT may contribute to AZT-induced muscle contractile dysfunction, and that antioxidant vitamin supplementation may help ameliorate this effect.
Subject(s)
Antioxidants/pharmacology , Diaphragm/drug effects , Muscle Contraction/drug effects , Zidovudine/toxicity , Animals , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/toxicity , Antioxidants/administration & dosage , Ascorbic Acid/administration & dosage , Ascorbic Acid/pharmacology , Diaphragm/physiopathology , Dietary Supplements , Female , In Vitro Techniques , Rats , Rats, Sprague-Dawley , Vitamin E/administration & dosage , Vitamin E/pharmacology , Zidovudine/administration & dosageABSTRACT
The purpose of this study was to examine the effect of varying recovery intervals on multiple-bout, short-duration, high-intensity cycling efforts of adult men supplemented with creatine (Cr) or a placebo (Pl). Thirty subjects underwent 3 trials of a maximal cycling protocol (T(0), T(1), T(2)). T(0) included V(O)2 max testing and familiarization with the sprint cycling protocol. T(1) consisted of 8 15-second bouts of sprint cycling exercise. Subjects were randomly assigned to recovery interval groups (1 minute, 3 minutes, 6 minutes), and Cr or Pl groups (0.3 g x kg(-1) x d(-1)). Posttesting (T(2)) took place 7 days after T(1) and consisted of an identical protocol as during T(1). Changes in mean power (MP), peak power (PP), and fatigue index (FI) were compared between trials. MP was significantly increased in Cr 1-minute, Cr 3-minute, and Pl 6-minute groups (p < 0.05). Significant PP increases were demonstrated in Cr 1-minute and Pl 6-minute groups (p < 0.05), and FI significantly increased in Pl 1-minute group (p < 0.05). Results indicate that Cr supplementation is effective in improving recovery from repeated sprint cycling performances when the recovery interval is of a short (<6 minutes) duration.